5.1 Enteral Access Modalities & Route Selection

5.1 Enteral Access Modalities & Route Selection

Clinical Core: The foundational axiom of clinical nutrition support is: "If the gut works, use it." Delivering nutrients directly into the gastrointestinal lumen provides physiological, immunologic, and metabolic benefits that cannot be duplicated by parenteral nutrition. Selecting the appropriate enteral access route requires systematic evaluation of gastrointestinal function, anticipated duration of therapy (using the 4-to-6-week threshold), aspiration risk, and unique patient anatomy. Clinicians must understand the distinct operational characteristics of short-term transnasal tubes, long-term percutaneous stomas, and skin-level devices to optimize outcomes and minimize mechanical and infectious morbidity.

---

Physiological Foundations: The Gut as an Immune and Metabolic Organ

For decades, the gastrointestinal tract was viewed merely as a passive organ for digestion and absorption. Contemporary nutritional immunology demonstrates that the gut is the body's largest immunologic organ, housing approximately 70% of total immune cells and producing vast quantities of protective antibodies. Luminal nutrient delivery exerts critical trophic and immunomodulatory effects:

1. Maintenance of Mucosal Architecture and Cellular Trophism

Enterocytes derive up to 70% of their daily energy requirements directly from luminal substrates (such as dietary glutamine in the small intestine and short-chain fatty acids like butyrate in the colon) rather than from systemic arterial circulation. The total absence of luminal nutrients (such as during prolonged bowel rest or exclusive parenteral nutrition) induces rapid gut mucosal atrophy within 48 to 72 hours:

• Blunting of Intestinal Villi: Microvillus height and total mucosal mass decrease dramatically, reducing the functional surface area available for nutrient transport.
• Depletion of Brush Border Enzymes: Critical disaccharidases (lactase, sucrase, maltase) and brush border peptidases decline, precipitating transient malabsorption upon the eventual resumption of feeding.
• Disruption of Epithelial Tight Junctions: The apical junctional complex—comprising claudins, occludins, and zonula occludens-1 ($ZO-1$)—loosens, dramatically increasing paracellular permeability.

2. Gut-Associated Lymphoid Tissue (GALT) and Secretory IgA (sIgA)

GALT and Mucosa-Associated Lymphoid Tissue (MALT) comprise organized lymphoid aggregates (Peyer's patches in the terminal ileum), lamina propria lymphocytes, and mesenteric lymph nodes. Luminal nutrient exposure provides the essential mechanical and antigenic stimulation required for immune homeostasis:

• B-Cell Priming and Mucosal Homing: Luminal antigens stimulate naive B cells in Peyer's patches to undergo class-switch recombination to IgA-producing plasma cells, which migrate to mucosal surfaces throughout the respiratory, genitourinary, and gastrointestinal tracts.
• Secretory IgA ($sIgA$): Plasma cells secrete dimeric IgA, which is coupled to the polymeric immunoglobulin receptor ($pIgR$) on enterocytes and transported into the luminal mucus layer as secretory IgA. In this OpenExamPrep guide curriculum, sIgA serves as the frontline non-inflammatory barrier: it binds pathogenic bacteria, viruses, and dietary macromolecules, preventing mucosal adhesion and cellular invasion (immune exclusion).
• Impact of Starvation: Gut rest reduces GALT cellularity, downregulates mucosal sIgA secretion, and impairs respiratory tract mucosal defense, significantly elevating pneumonia and systemic sepsis rates.

3. Prevention of Bacterial Translocation and SIRS

When the mucosal physical barrier (epithelial cells, tight junctions, mucus layer) and immunologic barrier (GALT, sIgA) break down, viable enteric bacteria (predominantly Gram-negative bacilli such as Escherichia coli, Klebsiella, and Enterobacter) and endotoxins (lipopolysaccharide, LPS) escape across the damaged epithelium into mesenteric lymph nodes, the portal vein, and systemic circulation. This process, termed bacterial translocation, triggers systemic macrophage activation, massive release of pro-inflammatory cytokines ($\text{TNF}-\alpha$, $\text{IL}-1\beta$, $\text{IL}-6$), and systemic inflammatory response syndrome (SIRS), which can culminate in multi-organ dysfunction syndrome (MODS).

$\text{Luminal Feeding} \longrightarrow \uparrow \text{Enterocyte Trophism} + \uparrow \text{sIgA} + \text{Intact Tight Junctions} \longrightarrow \Downarrow \text{Bacterial Translocation} + \Downarrow \text{SIRS}$

---

The Enteral Access Decision Algorithm

Selecting the optimal enteral access device follows a structured algorithmic pathway governed by four primary parameters:

1. Gastrointestinal Tract Function: Is the gut functional, accessible, and safe to use? (Contraindications include active bowel ischemia, complete mechanical bowel obstruction, severe peritonitis, and high-output proximal enterocutaneous fistulas where access distal to the fistula cannot be secured).
2. Anticipated Duration of Therapy: The standard clinical demarcation is 4 to 6 weeks:
   • Short-term (< 4 to 6 weeks): Transnasal or transoral tubes.
   • Long-term (> 4 to 6 weeks): Percutaneous endoscopic, radiologic, or surgical ostomy tubes.
3. Aspiration Risk and Gastric Motility: Is the stomach safe to feed, or is post-pyloric (duodenal/jejunal) access required?
4. Anatomic Constraints: Are there esophageal strictures, facial trauma, severe obesity, previous gastric resection, or intervening organs?

---

Short-Term Enteral Access Modalities (< 4 to 6 Weeks)

1. Nasogastric (NG) Tubes

Small-bore nasogastric tubes (8 to 12 French, made of flexible polyurethane or silicone) are the initial standard for acute enteral access.

• Physiological Merits: Replicating normal digestive physiology, the stomach acts as a natural reservoir, tolerating large-volume boluses (240 to 400 mL over 15 to 30 minutes) and intermittent gravity infusions. Gastric acid sterilizes ingested formula, and normal cephalic-gastric neuroendocrine signaling (gastrin, motilin) is preserved.
• Bedside Placement: Inserted blindly or with stylets at the bedside. Flexible tubes cause less trauma than stiff large-bore polyvinyl chloride (PVC) Salem sump tubes (which are designed for decompression, not long-term feeding).
• Complications: Epistaxis, sinusitis (due to ostial obstruction of paranasal sinuses), pharyngeal irritation, and alar pressure ulcers. Patients with altered mental status frequently dislodge or pull out transnasal tubes.

2. Orogastric (OG) Tubes

• Indications: Preferred in mechanically ventilated intensive care patients, premature neonates (who are obligate nasal breathers), and patients with severe facial or basilar skull trauma (cribriform plate fractures). In basilar skull trauma, blind transnasal tube placement is strictly contraindicated due to the lethal risk of intracranial catheter penetration.

3. Nasoduodenal (ND) and Nasojejunal (NJ) Tubes

• Design: Longer small-bore tubes (100 to 140 cm, 8 to 10 French) equipped with a flexible weighted tip (tungsten) or unweighted design.
• Placement Modalities:
  • Spontaneous Transpyloric Migration: Tube placed in stomach, patient placed in right lateral decubitus position, accompanied by intravenous prokinetic administration (erythromycin $200\text{--}250\text{ mg IV}$ or metoclopramide $10\text{ mg IV}$). Spontaneous migration success is variable (30% to 60%).
  • Bedside Electromagnetic Guidance (e.g., Cortrak): Utilizes an electromagnetic sensor stylet displaying real-time anatomical tracing on an external monitor as the tube advances through the esophagus, stomach, pylorus, and duodenum. Reduces radiation exposure and accelerates placement.
  • Fluoroscopic Placement: Interventional radiology utilizes guidewires and contrast injection under real-time fluoroscopy with success rates $> 95\%$.
  • Endoscopic Placement: Gastroenterologist visualizes pylorus directly, grasping the tube with biopsy forceps or passing a wire through the biopsy channel (over-the-wire technique) to advance the tip into the proximal jejunum.

---

Long-Term Enteral Access Modalities (> 4 to 6 Weeks)

1. Percutaneous Endoscopic Gastrostomy (PEG)

Introduced by Gauderer and Ponsky in 1980, the PEG tube is the gold standard for long-term enteral nutrition. Placed via push or pull endoscopic techniques, it requires successful endoluminal transillumination of the anterior abdominal wall and distinct 1:1 focal finger indentation.

• Contraindications:
  • Absolute: Inability to appose the gastric wall to the abdominal wall (e.g., prior subtotal gastrectomy, colon interposition, severe ascites), uncorrectable coagulopathy (INR $> 1.5$, platelets $< 50,000/\mu\text{L}$), active peritonitis, and hemodynamic instability.
  • Relative: Massive peritoneal dialysis (peritonitis risk), ventriculoperitoneal (VP) shunts (infection seeding risk), gastric varices, and morbid obesity (inability to transilluminate).

2. Percutaneous Radiologic Gastrostomy (PRG)

Also known as radiologically inserted gastrostomy (RIG), this technique is performed by interventional radiologists using fluoroscopy and ultrasound.

• Clinical Application: First-line access in patients with obstructive head and neck cancers, severe oropharyngeal tumors, radiation-induced trismus, or advanced esophageal strictures where an endoscope cannot pass.
• Technique: The stomach is distended with air via a temporary small catheter, and 2 to 4 gastropexy T-fasteners are deployed to tack the anterior gastric wall securely to the parietal peritoneum before Seldinger needle dilation and tube insertion.

3. Surgical Gastrostomy (Open or Laparoscopic Stamms)

Indicated when endoscopic or radiologic approaches are technically impossible due to anatomical distortion, or when a patient is already undergoing laparotomy for another surgical indication (e.g., trauma, tumor resection).

4. Jejunostomy Modalities: PEJ, D-PEJ, and Surgical Jejunostomy

• Percutaneous Endoscopic Jejunostomy (PEJ) / Direct PEJ (D-PEJ): Direct entry into a jejunal loop using an enteroscope. Technically demanding due to the rapid mobility of the small intestine, lack of fixed transillumination, and presence of extensive mesenteric vasculature.
• Surgical Jejunostomy: Placed via open laparotomy or laparoscopy using a needle catheter technique or a Witzel tunnel (serosal tunnel inversion to prevent fistulization). Standard of care following major upper gastrointestinal resections (e.g., esophagectomy, total gastrectomy, Whipple procedure).

5. Dual-Lumen Transgastric Gastrojejunostomy (PEG-J)

A standard PEG tube acts as a conduit through which a secondary, smaller-caliber jejunal extension tube (8 to 12 French) is threaded across the pylorus into the small intestine.

• Dual Functionality: The gastric port permits continuous or intermittent gravity drainage of gastric secretions (gastric decompression), relieving nausea and vomiting, while the jejunal port delivers elemental or polymeric formula (jejunal feeding).
• Vulnerabilities: Up to 30% to 50% of jejunal extension tubes suffer retrograde migration, curling back into the stomach due to retroperistalsis, retching, or coughing. Other issues include frequent tube occlusion (due to small lumen) and twisting.

---

Clinical Indications for Post-Pyloric (Duodenal & Jejunal) Feeding

The stomach is the preferred, most physiological route when it is usable. Post-pyloric feeding is appropriate when anatomy, aspiration risk, or persistent gastric intolerance makes gastric delivery unsafe or ineffective:

                                [ Gastrointestinal Tract Assessment ]
                                                 |
                   +-----------------------------+-----------------------------+
                   |                                                           |
       [ Functional Gastric Emptying ]                             [ Impaired Gastric Emptying / ]
       [ & Low Aspiration Risk       ]                             [ High Aspiration Risk        ]
                   |                                                           |
      +------------+------------+                                 +------------+------------+
      |                         |                                 |                         |
[ < 4-6 Weeks ]          [ > 4-6 Weeks ]                    [ < 4-6 Weeks ]          [ > 4-6 Weeks ]
      |                         |                                 |                         |
( Nasogastric /           ( Percutaneous                      ( Nasoduodenal /          ( Direct PEJ,   )
  Orogastric  )             Gastrostomy:                        Nasojejunal   )           Surgical J,   
                            PEG or PRG )                                                  or PEG-J      )

Common Post-Pyloric Indications

1. Severe Gastroparesis: Diabetic autonomic enteropathy, critical illness-associated gastroparesis, and post-viral dysmotility result in severe gastric retention. Infusing formula into a paralyzed stomach leads to massive distension, regurgitation, and catastrophic aspiration.
2. Gastric Outlet Obstruction: Mechanical blockage secondary to scarring from chronic peptic ulcer disease, duodenal hematoma, or obstructing antral/periampullary neoplasms.
3. Documented High Aspiration Risk: Patients with persistent witnessed regurgitation, recurrent aspiration pneumonia on gastric feeds, or severe gastroesophageal reflux disease unresponsive to prokinetic therapy and head-of-bed elevation.
4. Severe Acute Pancreatitis With Gastric Intolerance:
   • Early enteral nutrition is preferred to PN in stable patients predicted to have severe acute pancreatitis. A standard polymeric formula delivered by a nasogastric tube can be used first line.
   • Nasojejunal feeding is appropriate when nasogastric feeding is not tolerated because of persistent vomiting, gastric outlet dysfunction, or other documented gastric intolerance; pancreatitis alone does not require jejunal placement.
5. Altered Upper Gastrointestinal Anatomy: Status post-total or subtotal gastrectomy (Billroth II, Roux-en-Y reconstruction, or esophagectomy with gastric pull-up) where the gastric reservoir and pyloric sphincter are structurally absent or non-functional.

The Golden Rule of Small Bowel Feeding

Controlled Small-Bowel Delivery: The small intestine has much less reservoir capacity than the gastric fundus. New jejunal feeding is therefore usually started with an electronic pump at a low continuous rate (often $10\text{--}20\text{ mL/hr}$) and advanced according to tolerance. Avoid large rapid boluses that provoke cramping, diarrhea, or dumping symptoms. Selected stable patients may use a carefully prescribed cyclic or intermittent schedule under specialist supervision, so continuous delivery is the standard initial strategy rather than an exceptionless lifetime rule.

---

Low-Profile Gastrostomy Buttons (Skin-Level Devices)

Once a percutaneous gastrostomy tract has fully matured, standard long external dangling tubes can be replaced with a low-profile gastrostomy device (often called a skin-level button, such as the Mic-Key or AMT Mini ONE).

1. Indications and Quality of Life Benefits

• Pediatric Patients: Infants and active young children frequently dislodge standard gastrostomy tubes during play or daily activity. Low-profile buttons sit flush against the abdominal skin, concealed beneath clothing.
• Ambulatory Adults: Provides enhanced body image, unrestricted physical mobility, and discretion for adult patients receiving home enteral nutrition (HEN).
• Cognitively Impaired / Agitated Patients: Adult patients with advanced dementia, delirium, or traumatic brain injury frequently pull on dangling external tubes. A flush skin-level button eliminates this visual and tactile target, drastically reducing accidental self-extubation rates.

2. Retention Mechanism and Balloon Maintenance

Low-profile devices are typically retained within the gastric lumen by an inflatable silicone balloon (though non-balloon capsule or mushroom designs exist for specific pediatric uses).

• Inflation Liquid: Sterile Water ONLY:
  • The retention balloon must be filled exclusively with sterile water.
  • Contraindication to Normal Saline: Normal saline ($0.9\%\text{ NaCl}$) must NEVER be used. Over time, water evaporates across the silicone membrane, causing sodium chloride to crystallize within the inflation lumen and valve. These microcrystals block the valve mechanism, preventing deflation and necessitating invasive endo-surgical removal of the trapped device.
  • Contraindication to Ambient Air: Air must NEVER be used. Air molecules diffuse rapidly through the semipermeable silicone wall, leading to spontaneous balloon deflation, pericatheter leakage, and premature expulsion of the button from the stoma tract.
• Routine Maintenance Protocol:
  • Balloon volume must be verified weekly or bi-weekly.
  • Attach a Luer-slip syringe to the balloon port, aspirate the fluid completely, measure the recovered volume, and compare it against the manufacturer's specified volume (typically 3 to 5 mL in pediatric buttons, 5 to 10 mL in adult buttons).
  • Discard old fluid and reinstall fresh sterile water to the designated volume. If less than 80% of the volume is recovered, evaluate for a slow balloon leak.